SCHEMBL9545138

SCHEMBL9545138

O=C1C[C@H](c2cccnc2)C2(c3ccccc3-c3nccnc32)[C@@H](c2cccnc2)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
KDM4E B2RXH2 4/20 0.35
KMT2A Q03164 3/20 0.35
MAPT P10636 3/20 0.35
NPC1 O15118 1/20 0.35
HTT P42858 1/20 0.35
NPEPPS P55786 1/20 0.35
MEN1 O00255 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP2A6 P11509 1/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 1/20 0.34
PDK2 Q15119 2/20 0.33
RAB9A P51151 1/20 0.33
GPR174 Q9BXC1 1/20 0.33
GAA P10253 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9545130 1.00 CYP19A1 (0.37) CYP19A1NFKB1NFKB2RELAKDM4E
SCHEMBL9198100 0.89 NFKB1 (0.46) CYP19A1NFKB1NFKB2RELAKDM4E
SCHEMBL9198107 0.89 NFKB1 (0.46) CYP19A1NFKB1NFKB2RELAKDM4E
SCHEMBL9200820 0.81 CYP2A6 (0.40) KDM4EKMT2AMAPTNPEPPSMEN1
SCHEMBL9198802 0.72 NFKB1 (0.45) NFKB1NFKB2RELAKMT2AMAPT
SCHEMBL9195303 0.70 CYP2A6 (0.36) KMT2AMEN1CYP2A6PDK2GAA
SCHEMBL9199038 0.68 NFKB1 (0.35) CYP19A1NFKB1NFKB2RELAKMT2A
SCHEMBL9545528 0.67 GSK3B (0.38) KDM4EKMT2AMAPTNPC1L3MBTL1
SCHEMBL9545525 0.67 PDK2 (0.32) KMT2APDK2CYP1A2CYP2C19
SCHEMBL9198144 0.66 LIG1 (0.36) NFKB1NFKB2RELAHPGDPDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993021185-A1 SUBSTITUTED NITROGEN CONTAINING SPIRO COMPOUNDS FOR USE IN TREATING COGNITIVE DEFICITS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-10-28 WO disclosed